Stephane Bancel CEO of Moderna
In Good Company with Nicolai Tangen
Addressing Diversity in Vaccine Trials
This chapter addresses the challenges of achieving demographic diversity in a phase three vaccine clinical trial. It emphasizes efforts to enhance African-American representation and tackles the historical mistrust that affects participation in health studies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
